Evidence map›Paper›PMID 26658451›Full record

ArticleLaboratory investigation; a journal of technical methods and pathology2016

UM206, a selective Frizzled antagonist, attenuates adverse remodeling after myocardial infarction in swine.

André Uitterdijk, Kevin C M Hermans, Daphne P M de Wijs-Meijler, Evangelos P Daskalopoulos, Irwin K Reiss, Dirk J Duncker, W Matthijs Blankesteijn, Daphne Merkus

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Laboratory investigation; a journal of technical methods and pathology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Signaling pathways and targeted therapy for myocardial infarction.Signal transduction and targeted therapy · 2022
    Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. WNT Signaling in Cardiac and Vascular Disease.Pharmacological reviews · 2018
    Review
  16. Article
  17. Wnt/β-catenin pathway in tissue injury: roles in pathology and therapeutic opportunities for regeneration.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

André UitterdijkDepartment of Cardiology, Division of Experimental Cardiology, Thoraxcenter Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Kevin C M HermansDepartment of Pharmacology and Toxicology, Maastricht University, Maastricht, The Netherlands.
Daphne P M de Wijs-MeijlerDepartment of Cardiology, Division of Experimental Cardiology, Thoraxcenter Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Evangelos P DaskalopoulosDepartment of Pharmacology and Toxicology, Maastricht University, Maastricht, The Netherlands.
Irwin K ReissDepartment of Neonatology, Erasmus MC, Rotterdam, The Netherlands.
Dirk J DunckerDepartment of Cardiology, Division of Experimental Cardiology, Thoraxcenter Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
W Matthijs BlankesteijnDepartment of Pharmacology and Toxicology, Maastricht University, Maastricht, The Netherlands.
Daphne MerkusDepartment of Cardiology, Division of Experimental Cardiology, Thoraxcenter Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Erasmus MC · NLMaastricht University · NLErasmus University Rotterdam · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Modulation of Wnt/Frizzled signaling with UM206 reduced infarct expansion and prevented heart failure development in mice, an effect that was accompanied by increased myofibroblast presence in the infarct, suggesting that Wnt/Frizzled signaling has a key role in cardiac remodeling following myocardial infarction (MI). This study investigated the effects of modulation of Wnt/Frizzled signaling with UM206 in a swine model of reperfused MI. For this purpose, seven swine with MI were treated with continuous infusion of UM206 for 5 weeks. Six control swine were treated with vehicle. Another eight swine were sham-operated. Cardiac function was determined by echo in awake swine. Infarct mass was estimated at baseline by heart-specific fatty acid-binding protein ELISA and at follow-up using planimetry. Components of Wnt/Frizzled signaling, myofibroblast presence, and extracellular matrix were measured at follow-up with qPCR and/or histology. Results show that UM206 treatment resulted in a significant decrease in infarct mass compared with baseline (-41±10%), whereas infarct mass remained stable in the Control-MI group (+3±17%). Progressive dilation of the left ventricle occurred in the Control-MI group between 3 and 5 weeks after MI, while adverse remodeling was halted in the UM206-treated group. mRNA expression for Frizzled-4 and the Frizzled co-receptor LRP5 was increased in UM206-treated swine as compared with Control-MI swine. Myofibroblast presence was significantly lower in infarcted tissue of the UM206-treated animals (1.53±0.43% vs 3.38±0.61%) at 5 weeks follow-up. This study demonstrates that UM206 treatment attenuates adverse remodeling in a swine model of reperfused MI, indicating that Wnt/Frizzled signaling is a promising target to improve infarct healing and limit post-MI remodeling.

Indexed as

AnimalsFrizzled ReceptorsIntercellular Signaling Peptides and ProteinsMyocardial InfarctionSwineVentricular RemodelingWnt Signaling PathwayFrizzled ReceptorsIntercellular Signaling Peptides and Proteins

Identifiers

PMID26658451
OpenAlexW2194095661

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.